Associate Editor
Lanfranco Pellesi
- M.D./Ph.D.
- Clinical Pharmacologist/Neuroscientist
- lpellesi@health.sdu.dk
- University of Southern Denmark
Research Field
- Pathophysiology and Drug Discovery in Headache and Pain Disorders
- Translational Medicine and Clinical Pharmacology
- Artificial Intelligence and Innovative Pedagogical Models in Medical Research
Biography
Lanfranco Pellesi is an Assistant Professor at the University of Southern Denmark. He specializes in clinical pharmacology and neuroscience, with a research focus on the pathophysiological mechanisms of pain and headache disorders. His work integrates translational medicine, bridging preclinical models with clinical trials to identify novel therapeutic targets for migraine and cluster headaches. Dr. Pellesi has an extensive background in clinical trial investigations, having contributed to Phase 2 and Phase 3 studies on anti-CGRP monoclonal antibodies and investigator-initiated trials targeting VIP, PACAP, and KATP receptors. Beyond research, he is actively involved in medical education and AI-assisted learning models, leading flipped classroom experiences and problem-based learning initiatives.
Journal Information
- Journal: Brain Conflux
- Online ISSN: 3079-6016
- Publisher: Life Conflux Press Limited
- Peer Review: Single-anonymous
- Publication Model: Open Access
- Publishing Frequency: Quarterly
- Languages: English
- DOI Prefix: 10.71321
Submit Your Research
Fast-track peer review process
Journal Metrics
Impact factors & citation analysis
Research Areas
Clinical Neurology
Neuroimaging
Neurobiology
Neurosurgery
Psychiatry
Pediatric Neurology
AI in Neuroscience
Bioinformatics
Epidemiology
Geriatrics
Neuro-oncology
And many more specialized fields within brain sciences and medicine
For Authors & Reviewers
Publication Statistics
~28 days
Average Review Time
94%
Author Satisfaction
72%
Acceptance Rate
Global
Author Network
Open Access Benefits
✓
Immediate global accessibility
✓
No subscription barriers
✓
Enhanced citation potential
✓
Maximum research impact
Brain Conflux promotes open science principles, ensuring that groundbreaking research in life sciences and medicine reaches the global scientific community without barriers, accelerating scientific discovery and innovation.
Creative Commons License
Brain Conflux operates under a Creative Commons Attribution 4.0 International License, enabling unrestricted use, distribution, and reproduction while ensuring proper attribution to original authors and research integrity.
Copyright & Author Rights
Authors retain full copyright ownership of their work while granting Brain Conflux the right to publish and distribute. All submissions must comply with our rigorous ethical standards and originality requirements. Published content becomes freely accessible to the global research community, promoting scientific advancement and knowledge sharing.
Key Requirements: Original research, ethical compliance, proper citations, and agreement to publication terms.
Publication Ethics
Brain Conflux maintains the highest standards of publication ethics, preventing plagiarism, ensuring research integrity, and upholding international best practices. We implement comprehensive screening processes and follow COPE (Committee on Publication Ethics) guidelines to maintain scientific credibility.
Ethical Standards
COPE Certified
Digital Object Identifier
Every article receives a unique DOI through Crossref registration, ensuring permanent digital identification, reliable citation tracking, and long-term content preservation. This enhances discoverability and supports accurate academic referencing across global databases.
Recent Issues
